Showing 1‐10 of 32
Small Molecules
06 Aug 2024
Lonza Upgrades Clinical Manufacturing Services at Bend (US) Site to Include Bottling and Labeling Capabilities
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment New equipment to support bottling of...
Small Molecules
29 Apr 2024
Lonza Launches AI-Enabled Route Scouting Service to Accelerate Small Molecule Development
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs) The AI-driven route design...
Small Molecules
27 Mar 2024
Lonza Expands Service Offering for Spray-Dried Biologics for Pulmonary Delivery
New offering provides manufacturing of spray-dried protein formulations, nucleotide-based drugs and peptides for clinical and commercial supply
Small Molecules
08 Mar 2023
Lonza Upgrades Powder Characterization Capabilities at Tampa (US) Site
Lonza Tampa (US) upgrades powder characterization capabilities with the addition of universal powder flow testing and automated particle size and shape analysis systems  New...
Small Molecules
16 Jan 2023
Lonza Completes Expansion to Solid Form Services Facility at Bend (US) Site
The offering complements Lonza’s API development services and first-in-human services, aimed at the rapid advancement of small molecules New facility is based at Lonza’s Bend,...
Small Molecules
14 Sep 2022
Lonza Expands HPAPI Multipurpose Suite for Payload-Linker Manufacturing in Visp (CH)
Lonza adds further capacity for the manufacturing of antibody-drug conjugate (ADC) payloads Expanded multipurpose suite supports payload-linkers development and manufacturing...
Small Molecules
24 May 2022
Lonza and Israel Biotech Fund Collaboration Framework Agreement to Support Biologics and Small Molecules Development and Manufacture for Portfolio Companies; IBF to Facilitate Access to Israeli Market
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence...
Small Molecules
23 May 2022
Lonza to Expand Inhalation Capabilities at Tampa Site
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of continued focus on providing bioavailability enhancement series for global...
Small Molecules
09 May 2022
Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech Firms
Lonza to support ALSA Ventures’ portfolio companies with services supporting de-risking, early development and manufacturing of next-generation modalities ALSA Ventures to...
Small Molecules
31 Mar 2022
Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation Products
Lonza joins IPAC-RS,  the leading global voice of the orally inhaled and nasal drug products industry and committed to advancing science-based regulatory approaches...
1 2 3 4 >